Filtered Trial for Amlodipine Non-responder

PHASE3CompletedINTERVENTIONAL
Enrollment

531

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

September 30, 2008

Conditions
Hypertension
Interventions
DRUG

telmisartan+amlodipine

DRUG

amlodipine

Trial Locations (41)

Unknown

1235.13.037 Boehringer Ingelheim Investigational Site, Azumino, Nagano

1235.13.023 Boehringer Ingelheim Investigational Site, Higashiosaka, Osaka

1235.13.021 Boehringer Ingelheim Investigational Site, Itabashi-ku, Tokyo

1235.13.014 Boehringer Ingelheim Investigational Site, Kashihara, Osaka

1235.13.038 Boehringer Ingelheim Investigational Site, Kitaazumi-gun, Nagano

1235.13.009 Boehringer Ingelheim Investigational Site, Kiyose, Tokyo

1235.13.041 Boehringer Ingelheim Investigational Site, Kobe, Hyogo

1235.13.035 Boehringer Ingelheim Investigational Site, Komoro, Nagano

1235.13.003 Boehringer Ingelheim Investigational Site, Koriyama, Fukushima

1235.13.004 Boehringer Ingelheim Investigational Site, Koriyama, Fukushima

1235.13.027 Boehringer Ingelheim Investigational Site, Koriyama, Fukushima

1235.13.007 Boehringer Ingelheim Investigational Site, Koshigaya, Saitama,

1235.13.008 Boehringer Ingelheim Investigational Site, Koto-ku, Tokyo

1235.13.005 Boehringer Ingelheim Investigational Site, Matsudo, Chiba

1235.13.026 Boehringer Ingelheim Investigational Site, Mito, Ibaraki

1235.13.013 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1235.13.016 Boehringer Ingelheim Investigational Site, Okayama, Okayama,

1235.13.040 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1235.13.025 Boehringer Ingelheim Investigational Site, Saitama, Saitama

1235.13.001 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1235.13.024 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1235.13.028 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1235.13.030 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1235.13.031 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1235.13.033 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1235.13.034 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1235.13.002 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

1235.13.018 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

1235.13.019 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

1235.13.036 Boehringer Ingelheim Investigational Site, Shimoina-gun, Nagano

1235.13.042 Boehringer Ingelheim Investigational Site, Shinjuku-ku, Tokyo

1235.13.010 Boehringer Ingelheim Investigational Site, Shinjyuku-ku, Tokyo

1235.13.011 Boehringer Ingelheim Investigational Site, Shinjyuku-ku,Tokyo

1235.13.022 Boehringer Ingelheim Investigational Site, Shizuoka, Shizuoka

1235.13.015 Boehringer Ingelheim Investigational Site, Suita, Osaka,

1235.13.017 Boehringer Ingelheim Investigational Site, Takamatsu, Kagawa

1235.13.029 Boehringer Ingelheim Investigational Site, Takamatsu, Kagawa

1235.13.032 Boehringer Ingelheim Investigational Site, Takamatsu, Kagawa

1235.13.012 Boehringer Ingelheim Investigational Site, Takaoka, Toyama

1235.13.039 Boehringer Ingelheim Investigational Site, Takaoka,Toyama

1235.13.020 Boehringer Ingelheim Investigational Site, Tsuchiura, Ibaraki

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY